Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:18 AM
Ignite Modification Date:
2025-12-25 @ 2:18 AM
NCT ID:
NCT02028234
Eligibility Criteria:
Inclusion Criteria:
1. All consecutive patients undergone PTCA in our institution in the period between July 2013 and December 2013 will be eligible to be enrolled.
2. Positive biomarker indicating myocardial necrosis.
3. All patients with prior myocardial infarction (MI) or coronary artery bypass grafting; coronary artery disease will be included.
Exclusion Criteria:
1. Increased risk of bleeding (ex. active bleeding, major surgery \<30 days).
2. Allergy or adverse reactions to administered drugs.
3. Other drugs or medications that affect CYP3A4 mediated drug metabolism.
4. Patients with missing follow-up data will be dropped out from the study.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
85 Years
Study:
NCT02028234
Study Brief:
Protocol Section:
NCT02028234